(Boursier.com) – THE TREND
After the stress of late Friday and Monday, the lull continues in the markets. Trade tensions between the United States and China are easing … At least in tone! And probably temporarily, investors being accustomed for more than a year to warming and cooling sequences between China and the United States.
They still see the desire for Chinese appeasement and probably also rely on Trump's pragmatism. The US president said trade talks had taken place with China and others would follow … As long as this is a matter of debate … At this stage, no investor will venture to bet on a resolution of the conflict. commercial for the moment … For more than a year, the relationship between the first two economic powers of the planet passes through ups and downs and markets must resolve this uncertainty.
This morning, the CAC40 is expected close to balance at the opening. Overall, the remaining markets, despite the relaxation between the two giants, worried fears of a global recession.
Yesterday, moreover, the final version of the GDP of the United States confirmed such concerns, showing an increase of 2% year-on-year in the second quarter, compared to 2.1% in initial estimate and 3.1 % of the previous quarter.
The New York Stock Exchange ended on a solid rise Thursday night, boosted by the more conciliatory tone adopted by Beijing in the trade dispute with the United States. The Chinese Commerce Ministry said it was discussing with Washington a resumption of bilateral talks, and China was willing to resolve the problem calmly. This is enough to reassure the markets, which have been evolving for long weeks at the pace of progress and tensions between the two leading world economies.
At the close of business, the Dow Jones jumped 1.25% to 26,362 points, while the S & P 500 is gaining 1.27% to 2925 points. The Nasdaq advance of 1.48% to 7,973 points.
ECO AND CURRENCIES
German retail sales, adjusted for price, seasonality and calendar effects, fell 2.2% in July after rising 3% the previous month. The consensus was a decline of 1.3%. On a year-on-year basis, sales posted a strong increase of 4.4% but the month of July of 2019 had one more working day than July 2018, says the Federal Statistical Office.
La France :
– Consumer Price Index – provisional results – August. (8:45)
– Industry producer and import price indexes, July. (8:45)
– Monthly budgetary situation of the State, July. (8:45)
– Maintenance price index – improvement of buildings. (12.00)
– Turnover of food supermarkets, July. (12.00)
– Volume of sales in commerce, June. (12.00)
– Production index in services. (12.00)
– Agricultural price indices, July. (12.00)
– Producer price indices for services, second quarter. (12.00)
– Turnover in industry and construction, June. (12.00)
United States :
– Household income and expenditure. (14.30)
– Chicago Manufacturing Index PMI. (3:45 p.m.)
– Final index of US consumer sentiment at the University of Michigan. (16.00)
– Unemployment rate in Italy. (10.00)
– Consumer price (flash) in Europe. (11:00)
– Unemployment rate in Europe. (11:00)
– Preliminary index of consumer prices in Italy. (11:00)
The ounce of yellow metal is trading at $ 1,540. For its part, the euro / dollar parity reached $ 1.1044 this morning. The barrel of Brent is trading $ 61.04.
VALUES TO FOLLOW
BNP Paribas should submit an offer on the equity derivatives portfolio of Deutsche Bank and the French bank thinks to be able to push back the competing proposals to conclude an agreement in the coming weeks, said sources close to the case to Reuters.
Bastide Medical Comfort in the fourth quarter of 2018-2019 (April-June) achieved a turnover of 86.4 million euros, up 10%. Organic growth remained very dynamic over the quarter at + 6.8%, above the average for the first nine months of the year.
ID Logistics : Eric Hemar, the CEO confirms in an interview published by Boursier.com, looking at possible external growth operations: "We structured our approach this year with the creation of an M & A department in order to have a more systematic approach. analysis of the files we are looking at, we are studying several operations and I hope that some of them will be successful. "
Bone Therapeutics, Valbiotis, Total Gabon, Emova Group, Clasquin, Archos, UCAR, STEF
Pharnext : FDA requests additional Phase 3 for PXT3003.
Advicenne : start of the recruitment of the ARENA-2 study in the United States.
© 2019, Boursier.com